多维健康评估问卷可作为风湿科常规诊疗中筛查抑郁的有效工具
该研究在170例类风湿关节炎(RA)或脊柱关节炎(SpA)患者中,比较多维健康评估问卷(MDHAQ)与患者健康问卷9(PHQ-9)及医院焦虑抑郁量表抑郁域(HADS-D)筛查抑郁的一致性。结果显示MDHAQ-Dep(60症状清单回答“是”或4点量表评分≥2.2)与PHQ-9≥10和HADS-D≥8的一致性相似,可作为常规筛查工具。
要点
- MDHAQ-Dep与PHQ-9≥10的百分比一致率为83.3%,kappa为0.63。
- MDHAQ-Dep与HADS-D≥8的百分比一致率为81.7%,kappa为0.60。
- SpA患者MDHAQ各评分(含抑郁条目)均高于RA患者,且符合抑郁筛查标准者评分更高。
核心结论
- MDHAQ-Dep阳性(60症状清单回答“是”或4点量表评分≥2.2)筛查抑郁的结果与PHQ-9≥10或HADS-D≥8相似。
研究设计与样本
- 来自巴塞罗那、主要诊断为RA或SpA的患者完成MDHAQ、PHQ-9(抑郁≥10)和HADS-D(抑郁≥8)评估。
- 共纳入170例患者,其中RA 102例,SpA 68例;采用百分比一致率和kappa统计量化6种筛查标准之间的一致性。
主要发现
- 6种标准筛查抑郁阳性的比例在RA患者中为19.6%-32.4%,在SpA患者中为27.9%-44.8%。
- 所有MDHAQ评分(包括抑郁条目)在SpA患者中高于RA患者,且在各自诊断组内符合PHQ-9≥10和HADS-D≥8抑郁筛查标准者评分更高。
- MDHAQ筛查标准与PHQ-9≥10的最高百分比一致率为83.3%,对应标准为60症状清单回答“是”或4点量表评分≥2.2(即MDHAQ-Dep)。
- MDHAQ-Dep与HADS-D≥8的百分比一致率为81.7%,PHQ-9≥10与HADS-D≥8的百分比一致率为82.2%。
- kappa一致性系数:MDHAQ-Dep与PHQ-9≥10为0.63,MDHAQ-Dep与HADS-D≥8为0.60,PHQ-9≥10与HADS-D≥8为0.62。
关键数值与推荐
- MDHAQ包含2个抑郁条目:患者友好HAQ中1个条目按4点格式评分(0至3.3分),60症状清单中1个是/否条目。
- 6种筛查标准包括:60症状清单回答“是”、4点量表评分≥1.1、4点量表评分≥2.2、60症状清单回答“是”或4点量表评分≥2.2(MDHAQ-Dep)、PHQ-9≥10、HADS-D≥8。
临床怎么用
- 在RA和SpA患者的常规风湿科诊疗中,可使用MDHAQ-Dep(60症状清单回答“是”或4点量表评分≥2.2)筛查抑郁,其结果与PHQ-9≥10或HADS-D≥8相似。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To analyze the use of the Multidimensional Health Assessment Questionnaire (MDHAQ) to screen for depression, as compared to 2 reference standards, the Patient Health Questionnaire 9 (PHQ-9) and the Hospital Anxiety and Depression Scale depression domain (HADS-D). METHODS: Patients from Barcelona with a primary diagnosis of rheumatoid arthritis (RA) or spondyloarthritis (SpA) completed the MDHAQ, the PHQ-9 (depression ≥10), and the HADS-D (depression ≥8) measures. The MDHAQ includes 2 depression items, 1 in the patient-friendly HAQ, scored in a 4-point format from 0 to 3.3, and a yes/no item on a 60-symptom checklist. Percentage agreement and kappa statistics quantified the agreement between 6 screening criteria: yes on the 60-symptom checklist, a score of ≥1.1, a score of ≥2.2 on a 4-point scale, and either a response of yes on the 60-symptom checklist or scores of ≥2.2, PHQ-9 ≥10, and HADS-D ≥8. RESULTS: Depression screening was positive according to 6 criteria in 19.6-32.4% of 102 patients with RA, and 27.9-44.8% of 68 with SpA (total = 170). All MDHAQ scores, including depression items, were higher in patients with SpA compared to patients with RA, and within each diagnostic group in patients who met PHQ-9 ≥10 and HADS-D ≥8 depression screening criteria. The highest percentage agreement between an MDHAQ screening criterion versus PHQ-9 ≥10 was 83.3% for either an answer of yes on the 60-symptom checklist or a score of ≥2.2 on a 4-point scale, which we have termed MDHAQ-Dep. The agreement of MDHAQ-Dep versus HADS-D ≥8 was 81.7%, similar to the agreement of PHQ-9 ≥10 versus HADS-D ≥8, which was 82.2%. Kappa measures of agreement were 0.63 for MDHAQ-Dep versus PHQ-9 ≥10, 0.60 for MDHAQ-Dep versus HADS-D ≥8, and 0.62 for PHQ-9 ≥10 versus HADS-D ≥8. CONCLUSION: A positive MDHAQ-Dep response (either an answer of yes on a 60-symptom checklist or a score of ≥2.2 on a 4-point scale) yielded similar results to PHQ-9 ≥10 or HADS-D ≥8 to screen for depression in these RA and SpA patients.
引用
- Morlà RM, Li T, Castrejon I, et al. Multidimensional Health Assessment Questionnaire as an Effective Tool to Screen for Depression in Routine Rheumatology Care. Arthritis Care Res (Hoboken). 2021. PMID: 32986905. doi:10.1002/acr.24467
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。